The Scientific Progress Immunoglobulins in Neurology (SPIN) Award Program was launched in 2008 to support research into the use of immunoglobulins in neurology. Grifols proudly supports the SPIN Award Program and believes it demonstrates the company's commitment to innovation in this field of scientific endeavour. We consider the program to be a tangible contribution to the improvement of standards of care and outcomes for patients with neurological conditions.

Applications for the SPIN Award 2025 will be accepted between August 1, 2024, and January 31, 2025.

To see the 2024 SPIN Award winner,
please click here.